Table 2.
Prevalence of self-reported adverse effects of specific drugs relative to all adverse effects reported.
| n | % | |
|---|---|---|
| Alcohol | 421 | 47.6 |
| Cannabis | 168 | 19.0 |
| Cocaine | 80 | 9.0 |
| Ecstasy | 55 | 6.2 |
| Ketamine | 27 | 3.1 |
| Poppers | 25 | 2.8 |
| Psilocybin | 17 | 1.9 |
| Amphetamine | 17 | 1.9 |
| LSD | 15 | 1.7 |
| Synthetic Cathinones | 10 | 1.1 |
| Benzodiazepines | 9 | 1.0 |
| Methamphetamine | 9 | 1.0 |
| GHB | 8 | 0.9 |
| 2C Series | 6 | 0.7 |
| Prescription Opioids | 5 | 0.6 |
| Synthetic Cannabinoids | 4 | 0.5 |
| Tryptamines | 4 | 0.5 |
| Fentanyls/Novel Opioids | 2 | 0.2 |
| NBOMe | 2 | 0.2 |
| Heroin | 1 | 0.1 |
Note. Prevalence is relative to the 885 separate drug-related effects reported by 622 participants (31.9% of the full sample). Poppers refer to amyl or butyl nitrites.